Buy or sell Celularity stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Celularity Stock

Biotechnology company

Founded

2016

Notable Investors

Celgene

Headquarters

Warren NJ, US

Total Funding

$290M

About Celularity Stock

Celularity is a biotechnology company productizing allogeneic cells and tissues derived from the postpartum placenta. These materials have the ability to augment our immunity and longevity by amplifying the body’s ability to fight disease, heal, and regenerate itself. Celularity is using stem cells derived from the placenta to create transformative therapeutic options for complex medical conditions from cancer to Crohn’s disease. Celularity has over a dozen pre-clinical trials and Investigational New Drug applications (IND) in progress.

Investors

Celgene

Celularity

Human Longevity

Celularity

Sorrento Therapeutics

Celularity

United Therapeutics

Celularity

Funding History

September 2017$40.0M
February 2018$250M

Management

Founder & Chief Executive Officer

Robert Hariri

Chief Information Officer

Steven French

Chief Marketing Officer

Jerome Zeldis

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Celularity or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo